SlideShare a Scribd company logo
1
Case-Control Studies
Dr. M. Ismail Zubair MD. MSc
2
Objectives - Concepts
• Define, understand and identify (CCS)
• Understand the principles of selecting cases and
controls
• Understand the analysis of CCS
• Calculation and interpretation of the OR
• Understand the concept of matching
• Understand the origin and consequence of recall bias
• Example of measurement bias
• Advantages and disadvantages of CCS
3
4
5
6
7
Case-Control Studies (CCS)
• An alternative observational design to identify risk
factors for a disease/outcome.
• Question:
• How do diseased cases differ from non-diseased (controls)
with respect to prior exposure history?
• Compare frequency of exposure among cases and controls
• Effect cause.
• Cannot calculate disease incidence rates because the CCS
does not follow a disease free- population over time
8
9
10
11
12
13
Disease
+ -
Exp + a b
Exp - c d
d 1 d 0
Case-control Study – Design
Select subjects on the basis of disease status
14
Example CCS - Smoking and Myocardial Infarction
MI
+ -
Smk + 30 20
Smk - 10 20
•
40 40
OR = a . d = 30 . 20 = 3.0 (same as the RR!)
c . b 10 . 20
Study: Desert island, population = 2,000 people, prevalence of
smoking = 50% [but this is unknown], identify all MI cases that
occurred over last year (N=40), obtain a random sample of N=40
controls (no MI). What is the association between smoking and MI?
15
Examples of CCS
• Outbreak investigations
• What dish caused people at the church picnic to get sick?
• What is causing young women to die of toxic shock?
• Birth defects
• Drug exposures and heart tetralogy
• New (unrecognized) disease
• DES and vaginal cancer in adolescents
• Is smoking the reason for the increase in lung CA? (1940’s)
– Four CCS implicating smoking and lung cancer appeared in
1950, establishing the CCS method in epidemiology
16
Essential features of CCS design
• Directionality
• Outcome to exposure
• Timing
• Retrospective for exposure, but case ascertainment can be either
retrospective or prospective.
• Rare or new disease
• Design of choice if disease is rare or if a quick “answer” is needed
(cohort design not useful)
• Challenging
• The most difficult type of study to design and execute
• Design options
• Population-based vs. hospital-based
17
Selection of Cases
• Requires case-definition:
• Need for standard diagnostic criteria e.g., AMI
• Consider severity of disease? e.g., asthma
• Consider duration of disease
– prevalent or incident case?
• Requires eligibility criteria
• Area of residence, age, gender, etc
18
Sources of Cases
• Population-based
– identify and enroll all incident cases from a defined population
– e.g., disease registry, defined geographical area, vital records
• Hospital-based
• identify cases where you can find them
– e.g., hospitals, clinics.
• But……
– issue of representativeness?
– prevalent vs incident cases?
19
Selection of Controls
• Controls reveal the ‘normal’ or ‘expected’ level of
exposure in the population that gave rise to the
cases.
• Issue of comparability to cases – concept of the
“study base”
• Controls should be from the same underlying population or
study base that gave rise to the cases?
• Need to determine if the control had developed disease
would he or she be included as a case in the study?
– If no then do not include
• Controls should have the same eligibility criteria as
the cases
20
Sources of Controls
• Population-based Controls
– ideal, represents exposure distribution in the general
population, e.g.,
• driver’s license lists (16+)
• Medicare recipients (65+)
• Tax lists
• Voting lists
• Telephone RDD survey
• But if low participation rate = response bias
(selection bias)
21
Sources of Controls
• Hospital-based Controls
• Hospital-based case control studies used when population-
based studies not feasible
• More susceptible to bias
• Advantages
– similar to cases? (hospital use means similar SES, location)
– more likely to participate (they are sick)
– efficient (interview in hospital)
• Disadvantages
– they have disease?
• Don’t select if risk factor for their disease is similar to the
disease under study e.g., COPD and Lung CA
– are they representative of the study base?
22
Other Sources of Controls
• Relatives, Neighbors, Friends of Cases
• Advantages
– similar to cases wrt SES/ education/ neighborhood
– more willing to co-operate
• Disadvantages
– more time consuming
– cases may not be willing to give information?
– may have similar risk factors (e.g., smoke, alcohol, golf)
23
Disease
case control
Exp + a b
Exp - c d
d 1 d 0
• Odds of exposure among cases = a / c
• Odds of exposure among controls = b / d
24
Analysis of CCS
The OR as a measure of association
• The only valid measure of association for the CCS is the
Odds Ratio (OR)
• Under reasonable assumptions (– the rare disease
assumption) the OR approximates the RR.
• OR = Odds of exposure among cases (disease)
Odds of exposure among controls (non-dis)
– Odds of exposure among cases = a / c
– Odds of exposure among controls = b / d
– Odds ratio = a/c = a.d [= cross-product ratio]
b/d b.c
25
Example CCS - Smoking and Myocardial Infarction
MI
+ -
Smk + 30 20
Smk - 10 20
•
40 40
OR = a . d = 30 . 20 = 3.0 (same as the RR!)
c . b 10 . 20
Study: Desert island, population = 2,000 people, prevalence of
smoking = 50% [but this is unknown], identify all MI cases that
occurred over last year (N=40), obtain a random sample of N=40
controls (no MI). What is the association between smoking and MI?
26
Odds Ratio (OR)
• Similar interpretation as the Relative Risk
• OR = 1.0 (implies equal odds of exposure - no effect)
• ORs provide the exact same information as the RR if:
• controls represent the target population
• cases represent all cases
• rare disease assumption holds (or if case-control study is undertaken with
population-based sampling)
• Remember:
• OR can be calculated for any design but RR can only be calculated in RCT
and cohort studies
• The OR is the only valid measure for CCS
• Publications will occasionally mis-label OR as RR (or vice versa)
27
Controlling extraneous variables
(confounding)
• Exposure of interest may be confounded by a
factor that is associated with the exposure
and the disease i.e., is an independent risk
factor for the disease
A B
C
28
How to control for confounding
• At the design phase
– Randomization
– Restriction
– Matching
• At the analysis phase
– Age-adjustment
– Stratification
– Multivariable adjustment
29
Matching is commonly used in CCS
• Control an extraneous variable by matching
controls to cases on a factor you know is an
important risk factor or marker for disease
• Example:
– Age (within 5 years)
– Sex
– Neighbourhood
• If factor is fixed to be the same in the cases
and controls then it can’t confound
30
Matching
• Analysis of matched CCS needs to account
for the matched case-control pairs
• Only pairs that are discordant with respect to
exposure provide useful information
• Can increase power by matching more than 1
control per case e.g., 4:1
• Useful if few cases are available
31
Recall Bias
• Form of measurement bias.
• Presence of disease may affect ability to recall or
report the exposure.
• Example – exposure to OTC drugs during pregnancy
use by moms of normal and congenitally abnormal
babies.
• To lessen potential:
• Blind participants to study hypothesis
• Blind study personnel to hypothesis
• Use explicit definitions for exposure
• Use controls with an unrelated but similar disease
– E.g., heart tetralogy (cases), hypospadia (controls)
32
CCS - Advantages
• Quick and cheap (relatively)
• so ideal for outbreaks
(http://www.cdc.gov/eis/casestudies/casestudies.htm)
• Can study rare diseases (or new)
• Can evaluate multiple exposures (fishing
trips)
33
Case-control Studies - Disadvantages
• uncertain of E D relationship (esp.
timing)
• cannot estimate disease rates
• worry about representativeness of controls
• inefficient if exposures are rare
• Bias:
• Selection
• Confounding
• Measurement (especially recall bias)
Thank you
Questions and Comments
34

More Related Content

PPTX
Observational analytical study: Cross-sectional, Case-control and Cohort stu...
PPTX
Case control study
PPTX
Case control & other study designs-i-dr.wah
PDF
Study protocols development
PPTX
Case Control Study (ANALYTICAL EPIDEMIOLOGY)
PPTX
Case control study
PPTX
Cohort study
PPTX
Case Control Study Design
Observational analytical study: Cross-sectional, Case-control and Cohort stu...
Case control study
Case control & other study designs-i-dr.wah
Study protocols development
Case Control Study (ANALYTICAL EPIDEMIOLOGY)
Case control study
Cohort study
Case Control Study Design

What's hot (19)

PPTX
5. cohort studies
PPTX
Case control study
PPT
Lecture 5 case control & cross-sectional spring 2013
PPTX
Case control study - Part 2
PPTX
Case Study Control | Statistics
PPTX
Case control studies
PPTX
Epidemiological Studies
PPT
Analytical epidemiology
PPTX
Seminar case control study
PPT
Case control study by keshab chapagain
PPTX
Case control study
PPT
Epidemiological study designs
PPT
Epidemiology Study Design
PPTX
Cohort study and case control study
PDF
5. Case control
PPTX
Steps in cohort study
PPT
Malimu cohort studies
PDF
Case control studies
PPTX
Case control studies..skp
5. cohort studies
Case control study
Lecture 5 case control & cross-sectional spring 2013
Case control study - Part 2
Case Study Control | Statistics
Case control studies
Epidemiological Studies
Analytical epidemiology
Seminar case control study
Case control study by keshab chapagain
Case control study
Epidemiological study designs
Epidemiology Study Design
Cohort study and case control study
5. Case control
Steps in cohort study
Malimu cohort studies
Case control studies
Case control studies..skp
Ad

Similar to Epidemiological_Case_Control_Study_Design (20)

PPT
Case-control studies by Matthew Reeves BVSc, PhD.
PPT
EPI546_Lecture_9.ppt
PPTX
Case Control Studies.pptx
PPTX
Study designs
PPTX
Case control & cohort study
PPTX
Description of CASE-CONTROL STUDY DESIGN.pptx
PPT
Analytical Epidemiology.ppt epidemiology and its principles in health
PPTX
Analytical epidemiology seminar 3.pptx
PPT
Epidemiological Designs.ppt
PPT
epidemiology with part 1(complete) 2.ppt
PPT
Study Designs - Case control design by Dr Amita Kashyap
PPT
Analytical Epidemiology and survey procedures.ppt
PPT
2010-Epidemiology (Dr. Sameem) basics and priciples.ppt
PPTX
final.pptx
PDF
Case-Control Studies
PPTX
Case control study
PPTX
Case control study
PPTX
Descriptive epidemiology
PPTX
Analytical epidemiology
PPTX
Research Designs
Case-control studies by Matthew Reeves BVSc, PhD.
EPI546_Lecture_9.ppt
Case Control Studies.pptx
Study designs
Case control & cohort study
Description of CASE-CONTROL STUDY DESIGN.pptx
Analytical Epidemiology.ppt epidemiology and its principles in health
Analytical epidemiology seminar 3.pptx
Epidemiological Designs.ppt
epidemiology with part 1(complete) 2.ppt
Study Designs - Case control design by Dr Amita Kashyap
Analytical Epidemiology and survey procedures.ppt
2010-Epidemiology (Dr. Sameem) basics and priciples.ppt
final.pptx
Case-Control Studies
Case control study
Case control study
Descriptive epidemiology
Analytical epidemiology
Research Designs
Ad

More from Mohammad Ismail Zubair MD. MSc (10)

PPTX
Kandahar white area_mapping_summary_ppt_4_nov_2020
PPTX
Health debates and dialogues final version
PPT
Exploring the factors effecting mental health services
PPT
Corss_sectional _study_ design
PPTX
Snaphsot of ri's situation full version
PPTX
Introduction to epidemiology
PPTX
Barriers to routine_immunization_coverage_afghansitan_2018
PPTX
Qualitative researc data_analysis
PPTX
Vpd surveillance system
PPTX
Introduction qualitative research_methodology_with_animation_fmic
Kandahar white area_mapping_summary_ppt_4_nov_2020
Health debates and dialogues final version
Exploring the factors effecting mental health services
Corss_sectional _study_ design
Snaphsot of ri's situation full version
Introduction to epidemiology
Barriers to routine_immunization_coverage_afghansitan_2018
Qualitative researc data_analysis
Vpd surveillance system
Introduction qualitative research_methodology_with_animation_fmic

Recently uploaded (20)

DOCX
RUHS II MBBS Microbiology Paper-II with Answer Key | 6th August 2025 (New Sch...
PPTX
Transforming Regulatory Affairs with ChatGPT-5.pptx
PPTX
Human Reproduction: Anatomy, Physiology & Clinical Insights.pptx
DOC
Adobe Premiere Pro CC Crack With Serial Key Full Free Download 2025
PPTX
CHEM421 - Biochemistry (Chapter 1 - Introduction)
PPT
ASRH Presentation for students and teachers 2770633.ppt
PPT
Management of Acute Kidney Injury at LAUTECH
PPTX
neonatal infection(7392992y282939y5.pptx
PPTX
Respiratory drugs, drugs acting on the respi system
PDF
Intl J Gynecology Obste - 2021 - Melamed - FIGO International Federation o...
PPTX
DENTAL CARIES FOR DENTISTRY STUDENT.pptx
PPTX
Neuropathic pain.ppt treatment managment
PPTX
MANAGEMENT SNAKE BITE IN THE TROPICALS.pptx
PPTX
ACID BASE management, base deficit correction
PPTX
ca esophagus molecula biology detailaed molecular biology of tumors of esophagus
PPTX
antibiotics rational use of antibiotics.pptx
PDF
Handout_ NURS 220 Topic 10-Abnormal Pregnancy.pdf
PDF
Medical Evidence in the Criminal Justice Delivery System in.pdf
PPTX
Cardiovascular - antihypertensive medical backgrounds
PPTX
JUVENILE NASOPHARYNGEAL ANGIOFIBROMA.pptx
RUHS II MBBS Microbiology Paper-II with Answer Key | 6th August 2025 (New Sch...
Transforming Regulatory Affairs with ChatGPT-5.pptx
Human Reproduction: Anatomy, Physiology & Clinical Insights.pptx
Adobe Premiere Pro CC Crack With Serial Key Full Free Download 2025
CHEM421 - Biochemistry (Chapter 1 - Introduction)
ASRH Presentation for students and teachers 2770633.ppt
Management of Acute Kidney Injury at LAUTECH
neonatal infection(7392992y282939y5.pptx
Respiratory drugs, drugs acting on the respi system
Intl J Gynecology Obste - 2021 - Melamed - FIGO International Federation o...
DENTAL CARIES FOR DENTISTRY STUDENT.pptx
Neuropathic pain.ppt treatment managment
MANAGEMENT SNAKE BITE IN THE TROPICALS.pptx
ACID BASE management, base deficit correction
ca esophagus molecula biology detailaed molecular biology of tumors of esophagus
antibiotics rational use of antibiotics.pptx
Handout_ NURS 220 Topic 10-Abnormal Pregnancy.pdf
Medical Evidence in the Criminal Justice Delivery System in.pdf
Cardiovascular - antihypertensive medical backgrounds
JUVENILE NASOPHARYNGEAL ANGIOFIBROMA.pptx

Epidemiological_Case_Control_Study_Design

  • 1. 1 Case-Control Studies Dr. M. Ismail Zubair MD. MSc
  • 2. 2 Objectives - Concepts • Define, understand and identify (CCS) • Understand the principles of selecting cases and controls • Understand the analysis of CCS • Calculation and interpretation of the OR • Understand the concept of matching • Understand the origin and consequence of recall bias • Example of measurement bias • Advantages and disadvantages of CCS
  • 3. 3
  • 4. 4
  • 5. 5
  • 6. 6
  • 7. 7 Case-Control Studies (CCS) • An alternative observational design to identify risk factors for a disease/outcome. • Question: • How do diseased cases differ from non-diseased (controls) with respect to prior exposure history? • Compare frequency of exposure among cases and controls • Effect cause. • Cannot calculate disease incidence rates because the CCS does not follow a disease free- population over time
  • 8. 8
  • 9. 9
  • 10. 10
  • 11. 11
  • 12. 12
  • 13. 13 Disease + - Exp + a b Exp - c d d 1 d 0 Case-control Study – Design Select subjects on the basis of disease status
  • 14. 14 Example CCS - Smoking and Myocardial Infarction MI + - Smk + 30 20 Smk - 10 20 • 40 40 OR = a . d = 30 . 20 = 3.0 (same as the RR!) c . b 10 . 20 Study: Desert island, population = 2,000 people, prevalence of smoking = 50% [but this is unknown], identify all MI cases that occurred over last year (N=40), obtain a random sample of N=40 controls (no MI). What is the association between smoking and MI?
  • 15. 15 Examples of CCS • Outbreak investigations • What dish caused people at the church picnic to get sick? • What is causing young women to die of toxic shock? • Birth defects • Drug exposures and heart tetralogy • New (unrecognized) disease • DES and vaginal cancer in adolescents • Is smoking the reason for the increase in lung CA? (1940’s) – Four CCS implicating smoking and lung cancer appeared in 1950, establishing the CCS method in epidemiology
  • 16. 16 Essential features of CCS design • Directionality • Outcome to exposure • Timing • Retrospective for exposure, but case ascertainment can be either retrospective or prospective. • Rare or new disease • Design of choice if disease is rare or if a quick “answer” is needed (cohort design not useful) • Challenging • The most difficult type of study to design and execute • Design options • Population-based vs. hospital-based
  • 17. 17 Selection of Cases • Requires case-definition: • Need for standard diagnostic criteria e.g., AMI • Consider severity of disease? e.g., asthma • Consider duration of disease – prevalent or incident case? • Requires eligibility criteria • Area of residence, age, gender, etc
  • 18. 18 Sources of Cases • Population-based – identify and enroll all incident cases from a defined population – e.g., disease registry, defined geographical area, vital records • Hospital-based • identify cases where you can find them – e.g., hospitals, clinics. • But…… – issue of representativeness? – prevalent vs incident cases?
  • 19. 19 Selection of Controls • Controls reveal the ‘normal’ or ‘expected’ level of exposure in the population that gave rise to the cases. • Issue of comparability to cases – concept of the “study base” • Controls should be from the same underlying population or study base that gave rise to the cases? • Need to determine if the control had developed disease would he or she be included as a case in the study? – If no then do not include • Controls should have the same eligibility criteria as the cases
  • 20. 20 Sources of Controls • Population-based Controls – ideal, represents exposure distribution in the general population, e.g., • driver’s license lists (16+) • Medicare recipients (65+) • Tax lists • Voting lists • Telephone RDD survey • But if low participation rate = response bias (selection bias)
  • 21. 21 Sources of Controls • Hospital-based Controls • Hospital-based case control studies used when population- based studies not feasible • More susceptible to bias • Advantages – similar to cases? (hospital use means similar SES, location) – more likely to participate (they are sick) – efficient (interview in hospital) • Disadvantages – they have disease? • Don’t select if risk factor for their disease is similar to the disease under study e.g., COPD and Lung CA – are they representative of the study base?
  • 22. 22 Other Sources of Controls • Relatives, Neighbors, Friends of Cases • Advantages – similar to cases wrt SES/ education/ neighborhood – more willing to co-operate • Disadvantages – more time consuming – cases may not be willing to give information? – may have similar risk factors (e.g., smoke, alcohol, golf)
  • 23. 23 Disease case control Exp + a b Exp - c d d 1 d 0 • Odds of exposure among cases = a / c • Odds of exposure among controls = b / d
  • 24. 24 Analysis of CCS The OR as a measure of association • The only valid measure of association for the CCS is the Odds Ratio (OR) • Under reasonable assumptions (– the rare disease assumption) the OR approximates the RR. • OR = Odds of exposure among cases (disease) Odds of exposure among controls (non-dis) – Odds of exposure among cases = a / c – Odds of exposure among controls = b / d – Odds ratio = a/c = a.d [= cross-product ratio] b/d b.c
  • 25. 25 Example CCS - Smoking and Myocardial Infarction MI + - Smk + 30 20 Smk - 10 20 • 40 40 OR = a . d = 30 . 20 = 3.0 (same as the RR!) c . b 10 . 20 Study: Desert island, population = 2,000 people, prevalence of smoking = 50% [but this is unknown], identify all MI cases that occurred over last year (N=40), obtain a random sample of N=40 controls (no MI). What is the association between smoking and MI?
  • 26. 26 Odds Ratio (OR) • Similar interpretation as the Relative Risk • OR = 1.0 (implies equal odds of exposure - no effect) • ORs provide the exact same information as the RR if: • controls represent the target population • cases represent all cases • rare disease assumption holds (or if case-control study is undertaken with population-based sampling) • Remember: • OR can be calculated for any design but RR can only be calculated in RCT and cohort studies • The OR is the only valid measure for CCS • Publications will occasionally mis-label OR as RR (or vice versa)
  • 27. 27 Controlling extraneous variables (confounding) • Exposure of interest may be confounded by a factor that is associated with the exposure and the disease i.e., is an independent risk factor for the disease A B C
  • 28. 28 How to control for confounding • At the design phase – Randomization – Restriction – Matching • At the analysis phase – Age-adjustment – Stratification – Multivariable adjustment
  • 29. 29 Matching is commonly used in CCS • Control an extraneous variable by matching controls to cases on a factor you know is an important risk factor or marker for disease • Example: – Age (within 5 years) – Sex – Neighbourhood • If factor is fixed to be the same in the cases and controls then it can’t confound
  • 30. 30 Matching • Analysis of matched CCS needs to account for the matched case-control pairs • Only pairs that are discordant with respect to exposure provide useful information • Can increase power by matching more than 1 control per case e.g., 4:1 • Useful if few cases are available
  • 31. 31 Recall Bias • Form of measurement bias. • Presence of disease may affect ability to recall or report the exposure. • Example – exposure to OTC drugs during pregnancy use by moms of normal and congenitally abnormal babies. • To lessen potential: • Blind participants to study hypothesis • Blind study personnel to hypothesis • Use explicit definitions for exposure • Use controls with an unrelated but similar disease – E.g., heart tetralogy (cases), hypospadia (controls)
  • 32. 32 CCS - Advantages • Quick and cheap (relatively) • so ideal for outbreaks (http://www.cdc.gov/eis/casestudies/casestudies.htm) • Can study rare diseases (or new) • Can evaluate multiple exposures (fishing trips)
  • 33. 33 Case-control Studies - Disadvantages • uncertain of E D relationship (esp. timing) • cannot estimate disease rates • worry about representativeness of controls • inefficient if exposures are rare • Bias: • Selection • Confounding • Measurement (especially recall bias)
  • 34. Thank you Questions and Comments 34

Editor's Notes

  • #3: Italicized topics are covered in chapter but not in this lecture.
  • #4: Show Grimes’ taxonomy of studies diagram. Reviews the distinctions among the families of studies. Our interest today is in the center right – those (observational) studies in which the exposure is not manipulated and assigned, and the (analytical) studies in which there is a hypothesis being tested, which implies pre-planned comparison groups.
  • #12: Review of what case-control studies are – amass a group of cases and match with a group of controls (similar people without the outcome), then determine the likelihood of their having been exposed.
  • #32: Mis-classification of the exposure due to selective recall.
  • #33: Provide CDC website as tutorial for those interested in outbreak investigation.